Treatment with Nucala (mepolizumab) for three or more years is safe, and was effective at easing symptoms and reducing…
Articles by Patricia Inacio, PhD
In people with ANCA-associated vasculitis (AAV), evaluating kidney function by a test known as the estimated glomerular filtration rate…
ANCA-associated vasculitis (AAV) with kidney involvement is the most common cause of kidney disease among elderly people, but most…
Lower-than-normal counts of lymphocytes, a type of immune cell, are linked to a higher risk of severe infection in older…
The ANCA Renal Risk Score, known as the ARRS, was found to be better than standard methods at predicting the…
Rates of preterm delivery, lower-than-normal birth weight, and maternal disease flares are higher among pregnant women with ANCA-associated vasculitis (AAV)…
Nearly three-quarters of ANCA-associated vasculitis (AAV) patients treated with rituximab fail to mount an effective immune response against SARS-CoV-2,…
Smoking at any time during one’s lifetime leads to more advanced disease and worse prognosis for people with ANCA-associated…
Despite high response rates to treatment strategies to reduce ear, nose, and throat involvement in ANCA-associated vasculitis (AAV), relapses…
Researchers have proposed a new cut-off value for blood levels of anti-neutrophil cytoplasmic antibodies (ANCAs) to improve the accuracy of…